A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma.

Issa, Issa Ismail; Brøndum, Rasmus Froberg; Due, Hanne; Schmidt, Linnéa; Bøgsted, Martin; Dybkær, Karen

Issa, Issa Ismail; Brøndum, Rasmus Froberg; Due, Hanne; Schmidt, Linnéa; Bøgsted, Martin; Dybkær, Karen.

Afiliación

Issa II; Department of Haematology, Aalborg University Hospital, Aalborg 9000, Denmark.
Brøndum RF; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark.
Due H; Department of Haematology, Aalborg University Hospital, Aalborg 9000, Denmark.
Schmidt L; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark.
Bøgsted M; Department of Haematology, Aalborg University Hospital, Aalborg 9000, Denmark.
Dybkær K; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark.

Cancer Drug Resist ; 4(1): 208-222, 2021.

Article en En | MEDLINE | ID: mdl-35582014

Palabras clave

Bendamustine; diffuse large B-cell lymphoma; multiple myeloma; resistance gene signature

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Drug Resist Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google